Summary of Study ST004393

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002783. The data can be accessed directly via it's Project DOI: 10.21228/M8XK1H This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST004393
Study TitlePolar metabolites profiling in Human Fragile X Syndrome (FXS) and typically developing (TD) human plasma.
Study Summary​​Human but not mouse brain shows Fragile X mental retardation protein (FMRP)-dependent metabolic changes. Therefore, polar metabolites were measured and compared from plasma of human male with FXS (N=6) versus age-matched TD controls. A reduction of polar metabolites was found, mostly amino acids or their derivatives, TCA cycle and nucleotide metabolism intermediates.
Institute
UMass Chan Medical School
Last NameUMass Chan
First NameSpinelli Lab
Address55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
Emailspinellilab@gmail.com
Phone(508) 856-8989 ext. 68148
Submit Date2025-11-12
Raw Data AvailableYes
Raw Data File Type(s)mzML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2025-12-01
Release Version1
Spinelli Lab UMass Chan Spinelli Lab UMass Chan
https://dx.doi.org/10.21228/M8XK1H
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002783
Project DOI:doi: 10.21228/M8XK1H
Project Title:Metabolic Reprogramming during Human Neuron Differentiation Indicates Glutaminase as a Key Determinant in Fragile X Syndrome
Project Summary:Metabolic homeostasis gone awry is a contributor to, if not an underlying cause of, several neurologic disorders. Fragile X syndrome (FXS) is a neurodevelopmental disorder caused by a trinucleotide repeat expansion in FMR1 and consequent loss of the encoded protein FMRP, which results in downstream molecular, neurologic, and mitochondrial deficits that are linked to cognitive impairment. In human postmortem brain, many metabolites and solute carrier proteins are coordinately dysregulated, which also occurs during differentiation of human iPSCs into excitatory neurons. Metabolic tracing in FXS neurons demonstrates a dearth of glutamine deamidation to glutamate, which reduces anaplerosis into the TCA cycle, potentially hindering bioenergetic and biosynthetic functions of mitochondria. Mechanistically, aberrant expression of glutaminase isoforms in FXS is responsible for reduced glutaminolysis, thereby altering glutamate levels which may contribute to FXS.
Institute:UMass Chan Medical School
Last Name:UMass Chan
First Name:Richter Lab
Address:55 Lake Avenue North, Worcester, Massachusetts, 01605, USA
Email:spinellilab@gmail.com
Phone:(508) 856-8989 ext. 68148

Subject:

Subject ID:SU004552
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Gender:Male

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Genotype
SA521164FXS02Homo Sapien Male Plasma FXS
SA521165FXS03Homo Sapien Male Plasma FXS
SA521166FXS04Homo Sapien Male Plasma FXS
SA521167FXS05Homo Sapien Male Plasma FXS
SA521168FXS06Homo Sapien Male Plasma FXS
SA521169TD01Homo Sapien Male Plasma TD
SA521170TD02Homo Sapien Male Plasma TD
SA521171TD03Homo Sapien Male Plasma TD
SA521172TD04Homo Sapien Male Plasma TD
SA521173TD05Homo Sapien Male Plasma TD
SA521174TD06Homo Sapien Male Plasma TD
SA521175TD07Homo Sapien Male Plasma TD
Showing results 1 to 12 of 12

Collection:

Collection ID:CO004545
Collection Summary:FXS plasma samples were collected at Rush University Medical Center and TD plasma samples collected at UMASS Chan Medical School. Fresh blood samples were collected in purple cap K2EDTA tubes and spun at 3000 RPM for 10 minutes at 4deg to separate the plasma. All participants or their legal guardians, as appropriate, signed informed consent to the study.
Sample Type:Blood (plasma)

Treatment:

Treatment ID:TR004561
Treatment Summary:No special treatment. Tissue samples were collected from patient.

Sample Preparation:

Sampleprep ID:SP004558
Sampleprep Summary:For plasma, 10ul of sample was added to 90ul of 80% methanol and vortexed for 10mins before spinning to collect the supernatant containing extracted metabolites and vacuum dried. The extract was then resuspended in LC/MS grade water.

Chromatography:

Chromatography ID:CH005569
Instrument Name:Thermo Vanquish
Column Name:Merck SeQuant ZIC-HILIC (150 x 2.1mm,5um)
Column Temperature:25
Flow Gradient:20 min, 80% - 20% B; 0.5 min, 20% - 80% B; 7.5min, 80% B
Flow Rate:0.15ml/min
Solvent A:100% water; 0.1% ammonium hydroxide; 20mM ammonium carbonate
Solvent B:100% acetonitrile
Chromatography Type:HILIC

Analysis:

Analysis ID:AN007341
Analysis Type:MS
Chromatography ID:CH005569
Num Factors:2
Num Metabolites:63
Units:Peak area
  
Analysis ID:AN007342
Analysis Type:MS
Chromatography ID:CH005569
Num Factors:2
Num Metabolites:42
Units:Peak area
  logo